Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial
Top Cited Papers
- 1 February 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (3) , 623
- https://doi.org/10.1200/jco.2000.18.3.623
Abstract
PURPOSE: Treatment with cisplatin-based chemotherapy provides a modest survival advantage over supportive care alone in advanced non–small-cell lung cancer (NSCLC). To determine whether a new agent...Keywords
This publication has 30 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trialsStatistics in Medicine, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrumentPublished by Elsevier ,1995
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Discrete sequential boundaries for clinical trialsBiometrika, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952